Adherence to antiviral therapy is essential to achieve sustained virological responses in patients treated for hepatitis C. An important limitation to use of appropriate doses of ribavirin is development of anemia. The aim of this study is to identify risk factors associated with anemia in liver tra
Early predictors of antiviral treatment response in liver transplant recipients with recurrent hepatitis C genotype 1
✍ Scribed by Campos-Varela, I.; Esteban, J. I.; Bes, M.; Caralt, M.; Allende, H.; Rodríguez-Frías, F.; Salcedo, M. T.; Sauleda, S.; Charco, R.; Guardia, J.; Esteban, R.; Castells, L.
- Book ID
- 121669957
- Publisher
- John Wiley and Sons
- Year
- 2014
- Tongue
- English
- Weight
- 135 KB
- Volume
- 21
- Category
- Article
- ISSN
- 1352-0504
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
There are unresolved issues regarding sustained virological response (SVR), tolerance and risk of rejection following antiviral therapy in liver transplantation (LT). The aim of our study was to determine efficacy, rejection risk and factors associated with SVR. HCV-infected LT patients with at leas
Factors associated with sustained virological response (SVR) in patients treated for hepatitis C virus (HCV) recurrence after liver transplantation (LT) are unclear. Ninety-nine HCV-positive/hepatitis B surface antigen-negative patients received antiviral treatment (AVT) with interferon/peginterfero